Biomedical Catalyst: Accelerating Femtech

Commercial help and funding for early-stage companies, university spinouts and entrepreneurial-minded academics focused on women’s health.

Opportunity Details

When

Registration Opens

09/09/2024

Registration Closes

13/10/2024

Award

Workshops from subject experts, mentors and business coaches; opportunities to network and collaborate; tailored support to prepare for Innovate UK Biomedical Catalyst, with closed cohort funding of up to £100,000 to develop your innovation.

Organisation

Innovate UK

Share this opportunity

Find out more and apply

Accelerating FemTech helps UK-based, early-stage companies, university spinouts and entrepreneurial-minded academics focused on women’s health to gain the commercial and funding momentum they need for long-term success.

The programme is delivered by the Health Innovation Network (HIN) South London and partners across the UK. It utilises Innovate UK funding as part of the Biomedical Catalyst, in collaboration with the Medical Research Council. It builds upon the experience of running the award-winning DigitalHealth.London, Propel and other innovator support programmes from the health innovation networks. Accelerating FemTech is equity-free and cost-free.

The first cohort ran from May 2023 to January 2024. Alumni were awarded more than £1million in total funding through a special closed-call feasibility funding opportunity through the Innovate UK Biomedical Catalyst.

The second cohort will run between November 2024 and March 2025. Applications are open until midnight on 13 October 2024.

  • Accelerating FemTech is open to up to 20 early-stage companies, university spinouts and academic entrepreneurs that meet the following criteria:

    Early-stage companies, university spinouts and academic entrepreneurs

    This year, we’re broadening our Accelerating FemTech programme to support and champion innovations from early-stage companies, university spinouts and academic entrepreneurs.
    You can apply for Accelerating FemTech without forming a company. As part of the programme, we support innovators to prepare for Innovate UK’s Biomedical Catalyst, in collaboration with Medical Research Council. In order to be eligible for this funding, you must form a company.

    FemTech innovators

    Accelerating FemTech is tailored especially for innovators addressing urgent challenges in women’s health. We’re looking for innovators who have developed a FemTech solution and are looking to take it to the next level.

    UK based

    Accelerating FemTech utilises funding from Innovate UK Biomedical Catalyst, in collaboration with the Medical Research Council. This means only UK based academics, university spin-outs and SMEs can apply for Accelerating FemTech.

    In addition, to apply for the subsequent Innovate UK Biomedical Catalyst funding for a project, all of the project work must be carried out in the UK and intend to exploit the results from or in the UK.

    We welcome founders of all genders who have a product in this space.

  • The programme supports early-stage companies, university spinouts and entrepreneurial-minded academics from across the UK, who are looking to take their early-stage innovation to the next level. These innovations should address current challenges in women’s health, including menstruation management, chronic pelvic pain, maternity and neonatal safety, cervical screening and more.

    We would like the programme to be inclusive of innovations for trans women, and we would encourage any innovators creating products in this space to apply to the programme.

    FemTech also includes general health conditions that affect women disproportionally or differently, such as orthopaedic knee injuries, cardiovascular disease or osteoporosis.

    • Insightful workshops from subject experts on regulation, marketing, pitching and more
    • Individual support to navigate the NHS and engage with key stakeholders
    • Meetings with mentors and business coaches to help champion the important work taking place at your university or company
    • Opportunities to network and collaborate with peers from across the FemTech industry
    • Tailored support to prepare for Innovate UK Biomedical Catalyst, with funding to develop your innovation
  • The second cohort will run between November 2024 and March 2025.

    The 10 week programme will require you to commit to spend at least one days per week on average in order to benefit from the programme.

    The programme will require physical attendance to some events, with dates to be confirmed. For example, during the 10 week Accelerating FemTech learning programme, two days of your time will be required.

    The 10 week programme will require you to commit to spend at least one day per week on average from 18th November to the end of March 2025 to benefit from the programme.

    The programme will require physical attendance at three events. These are Tuesday 19 November 2024 and Wednesday 20 November 2024, Wednesday 22 January 2025 and Thursday 23 January 2025, and Thursday 6 March 2025.

  • Please see the list of frequently asked questions for further queries.

Related Opportunities

Biomedical Catalyst: AI in Health Accelerator Programme

Opens: 11/09/2024   Closes: 07/10/2024

Accelerator course and access to funding for startups and early-stage businesses using AI to solve complex, unmet healthcare problems.

More Information

Related programme

Biomedical Catalyst

Biomedical Catalyst

Helps transform innovative ideas into commercially viable businesses.

Close

Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.